Component

Functional recovery of desensitized TRPV1

Species, preparation, dose and limitations are retained on linked claims.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Blocking phosphatidylinositol-4-kinase prevented recovery of TRPV1 after prolonged capsaicin desensitization, linking recovery to PIP2 resynthesis.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    dose
    Prolonged capsaicin followed by lipid-kinase blockade
    duration
    Recovery interval
    evidence_access
    Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    evidence_scope
    literature_reviewed; model-specific source-derived curation
    experimental_model
    TRPV1-expressing cells with Kir2.1 PIP2 biosensor
    limitations
    High intracellular ATP and PIP2 resynthesis were required; this is an experimental machinery perturbation, not evidence that dietary ATP supplementation changes analgesia.
    nutrient_topic
    Capsaicin chapter; interacting nutrients, drugs, peptides and proteins retain their experimental settings. · Capsaicin
    organism
    TRPV1-expressing cells with Kir2.1 PIP2 biosensor
    plain_language
    Blocking phosphatidylinositol-4-kinase prevented recovery of TRPV1 after prolonged capsaicin desensitization, linking recovery to PIP2 resynthesis.
    primary_references
    Functional recovery from desensitization of vanilloid receptor TRPV1 requires resynthesis of phosphatidylinositol 4,5-bisphosphate. (2005). https://pubmed.ncbi.nlm.nih.gov/15888659/ DOI: 10.1523/JNEUROSCI.1296-05.2005
    route
    In vitro
    tissue
    Channel recovery after desensitization
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    Capsaicin: mechanism of action and interactions (2026-09-20) · lines 44–53

    Original AI-assisted source-specific curation with primary-study citations, model, exposure, route, duration, negative findings and limitations preserved. Not publisher full text. · supports · TRPV1-expressing cells with Kir2.1 PIP2 biosensor · source_derived_draft · unverified_draft

    ## capsaicin-pip2-recovery Blocking phosphatidylinositol-4-kinase prevented recovery of TRPV1 after prolonged capsaicin desensitization, linking recovery to PIP2 resynthesis. Model/species: TRPV1-expressing cells with Kir2.1 PIP2 biosensor Tissue/system: Channel recovery after desensitization Exposure: Prolonged capsaicin followed by lipid-kinase blockade Route: In vitro Duration: Recovery interval Limits: High intracellular ATP and PIP2 resynthesis were required; this is an experimental machinery perturbation, not evidence that dietary ATP supplementation changes analgesia. Primary reference: Functional recovery from desensitization of vanilloid receptor TRPV1 requires resynthesis of phosphatidylinositol 4,5-bisphosphate. (2005). https://pubmed.ncbi.nlm.nih.gov/15888659/ DOI: 10.1523/JNEUROSCI.1296-05.2005 Access: Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards